• Nie Znaleziono Wyników

Percutaneous patent foramen ovale closure in a patient with inferior vena cava filter

N/A
N/A
Info
Pobierz
Protected

Academic year: 2022

Share "Percutaneous patent foramen ovale closure in a patient with inferior vena cava filter"

Copied!
1
0
0

Ładowanie.... (Zobacz pełny tekst teraz)

Pobierz teraz ( 1 Stron )

Pełen tekst

(1)

www.kardiologiapolska.pl

Kardiologia Polska 2013; 71, 11: 1207; DOI: 10.5603/KP.2013.0307 ISSN 0022–9032

STUDIUM PRZYPADKU / CLINICAL VIGNETTE

Percutaneous patent foramen ovale closure in a patient with inferior vena cava filter

Przezskórne zamknięcie przetrwałego otworu owalnego u pacjentki z filtrem w żyle głównej dolnej

Robert Sabiniewicz

1

, Jarosław Meyer-Szary

1

, Piotr Potaż

1

, Miłosz Jaguszewski

2

1Department of Paediatric Cardiology and Congenital Heart Diseases, Medical University of Gdansk, Poland

2Cardiovascular Centre of Cardiology, University Hospital of Zurich, Switzerland

A 26-year-old female with metastatic ovarian cancer, peritoneal metastases and vessel invasion was referred for pa- tent foramen ovale (PFO) closure. Due to massive pulmonary embolisation the patient had undergone the procedure of the OptEase (Cordis) inferior vena cava (IVC) filter implantation. The primary cancer was surgically excised and the patient qualified for further chemotherapy. Despite the administration of subcutaneous fraxiparine for thromboembolic prophylaxis, the patient subsequently had six transient ischaemic attacks. Baseline transoesophageal echocardiography (TEE) with air contrast revealed PFO with right-to-left shunt during the Valsalva manoeuvre. Therefore, the patient un- derwent percutaneous PFO closure. The procedure was performed via right transfemoral access, utilising an 8 F sheath to pass by the IVC filter and successfully deliver the 25-mm Amplatzer PFO device (Fig. 1A). During the procedure, no displacement of the filter was observed (Fig. 1B). A two day follow-up TEE revealed no contrast right-to-left atrial shunt.

The clinical post-procedural course was uneventful. Percutaneous closure of PFO is currently one of the methods of secondary prevention of cryptogenic cerebral stroke. Routinely used femoral access for PFO closure constitutes a major risk factor comprising filter displacement or entanglement of the guidewire or transporting sheath in a case of indwell- ing IVC filter. Herein we present a rare case of possible PFO closure through the IVC filter in a patient with a complex medical history which still remains challenging in standard clinical practice. The Amplatzer device was selected for its compatibility with small sheaths, which is of great importance while bypassing the filter.

Address for correspondence:

Robert Sabiniewicz, MD, PhD, Department of Paediatric Cardiology and Congenital Heart Diseases, Medical University of Gdansk, ul. Dębinki 7, 80–952 Gdańsk, Poland, e-mail: sabini@gumed.edu.pl

Conflict of interest: none declared

Figure 1. Passing of the filter with a catheter and removing the sheath; A. Passing of the filter with a catheter; B. Removing the sheath after successful implantation

A B

Cytaty

Pobierz teraz ( PDF - 1 Stron - 228.77 KB )

Powiązane dokumenty

Pulmonary vein isolation in a patient with atrial fibrillation and a filter in the inferior vena cava

Pulmonary vein isolation in a patient with atrial fibrillation and a filter in the inferior vena cava.. Dariusz Rodkiewicz 1 , Marek Kiliszek 2 , Edward Koźluk 1 , Agnieszka

Pediatric cardiologyPercutaneous atrial septal defect closure by using jugular venous access in a case with interrupted inferior vena cava

It is hard to locate in pulmonary vein by femoral venous approach and deploying the device in the cases with inferior vena continuation to superior vena cava.. Al- though there

ORIGINAL PAPERTranscatheter closure of atrial septum defect type II or patent foramen ovale using Amplatzer occluders in local anaesthesia – single center experience

Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with

Case reportPercutaneous closure of persistent ductus arteriosus in a patient with discontinuous inferior caval vein and situs inversus - a case report

Przeznaczyniowe zamkniêcie dro¿nego przewodu têtniczego Botalla u pacjentki z brakiem ci¹g³oœci ¿y³y g³ównej dolnej i odwróceniem trzewi – opis przypadku.. Percutaneous

DEBATEIschaemic stroke in a patient with patent foramen ovale (PFO): secondary preventionNeurologist’s statepointHubert Kwieciński

Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed

Patent foramen ovale closure versus medical therapy after cryptogenic stroke: An updated meta-analysis of all randomized clinical trials

6.8%5.23.3% (1.38 per 100 patient-years)61: 5.4%2: 11.3% P-value0.370.340.157 (0.08)< 0.0011: 0.002 2: 0.04 CLOSE — Patent Foramen Ovale Closure or Anticoagulants

Patent foramen ovale and left atrial appendage flow velocity predict atrial fibrillation recurrence post cryoballoon ablation

This study proposed a novel TEE-derived AF recurrence risk factor - the presence of patent foramen ovale - and confirmed the prognostic value of left atrium appendage late

Interventional closure of patent foramen ovale in prevention of thromboembolic events. Consensus document of the Association of Cardiovascular Interventions and the Section of Grown‑up Congenital Heart Disease of the Polish Cardiac Society

Abbreviations: AF, atrial fibrillation; ASCOD, atherosclerosis, small -vessel disease, cardiac pathology, other causes; CLOSE, Patent Foramen Ovale Closure or Anticoagulation